PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...

We came across a bullish thesis on Precision Drilling Corporation (PDS) on Substack by Nugget Capital Partners. In this ...

today announced that an abstract submitted by the National Cancer Institute (“NCI”) reporting clinical data on PDS01ADC, the Company’s IL-12 fused antibody drug conjuga PDS Biotechnology ...

NCI presentation to highlight IL-12 fused antibody drug conjugate during poster presentationPRINCETON, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- ...

Q4 2024 Earnings Call Transcript March 27, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.29. Operator: Good morning. And welcome to PDS ...

In 2021, Converge Technology Solutions acquired mobility and application specialist OPIN Digital Inc.; data analytics firm ... today of Delaware-based PDS Holding Company includes Paragon ...

PDS Biotechnology reported a loss per share of $1.03 for the year, narrower than the $1.39 reported for 2023 and better than an analyst estimate of $1.11, according to FinChat data. Net loss ...

Nasdaq Dividend History provides straightforward stock’s historical dividends data. Dividend payout record can be used to gauge the company's long-term performance when analyzing individual stocks.

NCI presentation to highlight IL-12 fused antibody drug conjugate during poster presentation PRINCETON, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB ...

PRINCETON, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq ... Cancer Institute (“NCI”) reporting clinical data on PDS01ADC, the Company’s IL-12 fused antibody ...